chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: COVID19
Symptoms: Chills, Malaise, Pain, Pyrexia
Clinical narrative: chills; fever; not feeling well; aches and pain; This is a spontaneous report from a contactable consumer or other non HCP. A 72-year-old male patient received BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number was not reported) via unspecified route of administration on unspecified date as dose 2, single for COVID-19 immunization. The patient's medical history and concomitant medication were not reported. On an unspecified date the patient experienced chills, fever, not feeling well, aches and pain. Reporter queried if patient could take aspirin, ibuprofen or Tylenol for the events. Outcome of the events was unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: PNC13
Symptoms: Rash
Clinical narrative: Developed a full facial rash and down on her back as well; This is a spontaneous report from a contactable consumer via medical information team. A female patient of an unspecified age received pneumococcal 13-valent conjugated vaccine (diphtheria crm197 protein) (PREVNAR 13, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for immunization. The patient medical history and concomitant medications were not reported. It was reported that after receiving the vaccine on an unknown date, the patient developed a full facial rash and down on her back as well. The reporter has done what she could to help treat the skin of the patient, and she talked to the pediatrician and sent her some pictures, but she mentioned that she could not be sure if the rash was caused by the vaccine until she sees it in person. The outcome of the event was unknown.   No follow-up attempts are possible. Information about batch/lot number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: she is having regular knee pain; This is a spontaneous report from a contactable consumer (patient) via Pfizer-sponsored program. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number and expiry date not reported), via an unspecified route of administration on 27Mar2021 as dose 1, single for COVID-19 immunization. Medical history included arthritis. The patient's concomitant medications were not reported. The patient experienced regular knee pain on an unspecified date. Therapeutic measures taken as a result of the events included Aleve (for pain). The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site pain
Clinical narrative: Fever; Soreness at injection site; This is a spontaneous report from a contactable consumer (patient) received via COVAES. A non-pregnant 26-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered on the left arm on 31Mar2021 09:00 (Lot Number: ER8733) (at the age of 26 years old) as dose 2, single for COVID-19 immunisation. The patient's medical history included known allergies: Citrus foods. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination nor was tested for COVID-19 since vaccination. Concomitant medications included phentermine (PHENTERMINE) taken for an unspecified indication. The patient previously received BNT162B2, administered on the left arm on 10Mar2021 08:30 (Lot number: EN6206) (at the age of 26 years old) as dose 1, single for COVID-19 immunisation and experienced soreness at injection site. On 31Mar2021 at 13:00, 4 hours after the vaccination, the patient experienced soreness at injection site, and at 23:00, 14 hours after the vaccination, the patient experienced fever. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department, or urgent care. Therapeutic measures were taken as a result of the events soreness at injection site and fever which included paracetamol (TYLENOL) and ascorbic acid (VITAMIN C). The patient recovered from the events on unspecified dates in 2021.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Arthropathy
Clinical narrative: wrist started bothering her; This is a spontaneous report from a contactable consumer (patient) via Medical Information team. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date in 2021, the patient's wrist started bothering her and she went to her wrist surgeon and received a steroid injection on 23Mar2021. She also stated that she received her second Pfizer vaccine dose on 24Mar2021. She received the steroid shot in her right wrist and received her vaccine dose in her left arm. The patient asked if she screwed up her second vaccine by getting the steroid shot the day prior. The outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Dysgeusia, Fatigue, Hypersensitivity, Oral discomfort
Clinical narrative: joint pain; fever; sore throat; Hypersensitive tongue (tip) and lips; metallic taste; Annoying enough to try and avoid contact to lips and tongue from surrounding tissue and teeth.; tiredness; This is a spontaneous report from a contactable consumer. A 57-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown), via an unspecified route of administration on arm left on 27Mar2021 12:45 AM (age at vaccination: 57 years) as dose 1, single for COVID-19 immunization at Pharmacy or Drug Store. The patient medical history included Chronic pain associated with stenosis of C-spine. Known allergies included Penicillin, Motrin (nsaid's), lemon grass, meat tenderizer (green papaya). If covid prior vaccination was reported as unknown. Covid tested post vaccination was reported as no. The patient Concomitant medications included paracetamol (Tylenol), Tizanidine, amitriptyline taken for unspecified indication from an unknown date. Other vaccine in four weeks was reported as no. On 31Mar2021 06:00 PM, the patient had some of the common side effects, joint pain, fever, tiredness, sore throat. I also at 1 wk out I am having an additional side effects not listed. Hypersensitive tongue (tip) and lips. Also a metallic taste in this area. Annoying enough to try and avoid contact to lips and tongue from surrounding tissue and teeth. Therapeutic measures were not taken as a result of events. The outcome of events was not resolved.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pyrexia
Clinical narrative: joint pain; fever; sore throat; Hypersensitive tongue (tip) and lips; metallic taste; Annoying enough to try and avoid contact to lips and tongue from surrounding tissue and teeth.; tiredness; This is a spontaneous report from a contactable consumer. A 57-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown), via an unspecified route of administration on arm left on 27Mar2021 12:45 AM (age at vaccination: 57 years) as dose 1, single for COVID-19 immunization at Pharmacy or Drug Store. The patient medical history included Chronic pain associated with stenosis of C-spine. Known allergies included Penicillin, Motrin (nsaid's), lemon grass, meat tenderizer (green papaya). If covid prior vaccination was reported as unknown. Covid tested post vaccination was reported as no. The patient Concomitant medications included paracetamol (Tylenol), Tizanidine, amitriptyline taken for unspecified indication from an unknown date. Other vaccine in four weeks was reported as no. On 31Mar2021 06:00 PM, the patient had some of the common side effects, joint pain, fever, tiredness, sore throat. I also at 1 wk out I am having an additional side effects not listed. Hypersensitive tongue (tip) and lips. Also a metallic taste in this area. Annoying enough to try and avoid contact to lips and tongue from surrounding tissue and teeth. Therapeutic measures were not taken as a result of events. The outcome of events was not resolved.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Illness, Pyrexia
Clinical narrative: sick; stomach problems; fever; This is spontaneous report from a contactable consumer (patient) via a Pfizer sponsored program. A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 VACCINE, Solution for injection, Batch/Lot Number: not reported) via an unspecified route of administration on 23Feb2021 as dose 1, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient stated that that she missed her second dose appointment because she got the first dose on 23Feb2021 and after that she was not able to get the second dose because she got sick with fever and stomach problems. she got another second dose appointment for 30Mar2021. No unaddressed medical questions referred or forwarded to medical information. The outcome of all the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Eye pruritus, Myalgia, Nasal congestion, Nasopharyngitis, SARS-CoV-2 test
Clinical narrative: symptoms similar to that of a cold / Cold symptoms; congestion; sneezing; itchy eyes; muscle aches; This is a spontaneous report from a contactable consumer (patient). A 64-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection and batch no: not reported/lot number: ER2613), via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunization. Medical history included smoker. There were no concomitant medications. Historical vaccine included patient received her first dose of bnt162b2 (PFIZER-BIONTECH covid-19 vaccine, formulation: solution for injection, batch no/lot number: not reported) via an unspecified route of administration, on an unknown date (at the age of 64-year-old) as dose 1, single for COVID-19 immunization and experienced muscle ache and received Flu vaccine (FLU VACCINE VII) on an unspecified date in 2021 for immunization. Patient said that after receiving the 2nd dose Pfizer-BioNTech Covid-19 Vaccine, she developed symptoms similar to that of a cold on 28Mar2021. These include congestion, sneezing, and itchy eyes. Patient also said she experienced muscle aches all week. The muscle aches started the same day she got the second dose, that night. Stated she got the 2nd dose at 15:00 and that night she was not feeling well and the next day more so. Stated that just today on 02Apr2021 was her first day she doesn't have the muscle aches, they aren't totally gone but it was improved. Patient relays that the cold symptoms are congestion, sneezing, and itchy eyes. States she was a smoker, and a cold typically goes into her lungs in her chest, and it didn't so that was a good thing the vaccine did for her if it was a real cold. Patient stated that the cold symptoms started 28Mar2021 and are not getting better, they are persisting. Patient provides that she got a Covid test the other day because the muscle aches were so bad, and the cold came from nowhere. She already having the muscle aches and thinks those should go away after a week. She usually gets muscle aches like after the flu vaccine last year and after her 1st dose. The patient underwent lab tests and procedures which included sars-cov-2 test was negative on 31Mar2021. The outcome of the event muscle ache was resolving, and other events was not resolved.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Sneezing
Clinical narrative: symptoms similar to that of a cold / Cold symptoms; congestion; sneezing; itchy eyes; muscle aches; This is a spontaneous report from a contactable consumer (patient). A 64-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection and batch no: not reported/lot number: ER2613), via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunization. Medical history included smoker. There were no concomitant medications. Historical vaccine included patient received her first dose of bnt162b2 (PFIZER-BIONTECH covid-19 vaccine, formulation: solution for injection, batch no/lot number: not reported) via an unspecified route of administration, on an unknown date (at the age of 64-year-old) as dose 1, single for COVID-19 immunization and experienced muscle ache and received Flu vaccine (FLU VACCINE VII) on an unspecified date in 2021 for immunization. Patient said that after receiving the 2nd dose Pfizer-BioNTech Covid-19 Vaccine, she developed symptoms similar to that of a cold on 28Mar2021. These include congestion, sneezing, and itchy eyes. Patient also said she experienced muscle aches all week. The muscle aches started the same day she got the second dose, that night. Stated she got the 2nd dose at 15:00 and that night she was not feeling well and the next day more so. Stated that just today on 02Apr2021 was her first day she doesn't have the muscle aches, they aren't totally gone but it was improved. Patient relays that the cold symptoms are congestion, sneezing, and itchy eyes. States she was a smoker, and a cold typically goes into her lungs in her chest, and it didn't so that was a good thing the vaccine did for her if it was a real cold. Patient stated that the cold symptoms started 28Mar2021 and are not getting better, they are persisting. Patient provides that she got a Covid test the other day because the muscle aches were so bad, and the cold came from nowhere. She already having the muscle aches and thinks those should go away after a week. She usually gets muscle aches like after the flu vaccine last year and after her 1st dose. The patient underwent lab tests and procedures which included sars-cov-2 test was negative on 31Mar2021. The outcome of the event muscle ache was resolving, and other events was not resolved.  No follow-up attempts are possible. No further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: Welts; Welts are itchy; This is a spontaneous report from a contactable consumer (patient) or other non-health care professional via Pfizer. A 64-year-old non-pregnant female patient received second dose of bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: ER8732) via an unspecified route of administration, administered in left arm on 01Apr2021 13:45 (at the age of 64-year-old) as single dose and first dose of bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EN6208) via an unspecified route of administration, administered in left arm on 11Mar2021 01:30 as single dose for COVID-19 immunization. Medical history included latex sensitivity and penicillin allergy from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient did not received any other medications within 2 weeks of vaccination. The patient was not diagnosed with COVID-19 prior to the vaccination. The patient had been not tested for COVID-19 since the vaccination. On 12Mar2021 06:00, the next morning the patient had welts, appeared not near vaccine location. First appeared on lower arm, wrist, then on ankle, then on side of body, welts were itchy. Patient thought it might have been a bug bite the first time, but it has happened again after the second injection. No treatment received for the events. No unaddressed medical questions referred or forwarded to Medical Information. The outcome of the events were unknown.  No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Extreme pain in her left shoulder and she cannot move her arm at all; This is a spontaneous report from a Pfizer-sponsored program.  about a contactable consumer or other non-health care professional (patient).   A 62-years-old female patient received second dose of BNT162B2 (COMIRNATY, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administrated in left arm on an unspecified date (on last Saturday) as dose 2, single for covid-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, 4-5 hours after vaccination, patient experienced extreme pain in her left shoulder, a lot of pain in her shoulder and she was in serious pain, and she cannot move her arm at all and has it in a makeshift sling. Patient stated that pain was between the shoulder blades, and she cannot pull her arm away from her side. Patient stated that this was going on the seventh day. She would like to know if that was normal or has been reported before. She has called the CDC as well and no one wants to tell her anything they keep sending her to someone else. She spoke with her doctor, and she was taking 1600 mg of ibuprofen and a muscle relaxant for the pain, but it was not helping, and the doctor does not want to do anything else. The outcome of the event was reported as unknown.   No follow-up attempts are possible; Information on Lot/Batch number cannot be obtained.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Bowel movement irregularity, Pruritus
Clinical narrative: itchiness from head to toes; Stomach cramping; had 8 bowel movements; This is a spontaneous report from a contactable consumer (patient) received via the Medical Information Team. A 62-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), via an unspecified route of administration, on 12Mar2021 (Batch/Lot number was not reported) (at the age of 62 years old) as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On 12Mar2021, the patient experienced itchiness from head to toes (at 07:00 PM), stomach cramping, and had 8 bowel movements. Clinical course of events was as follows: The patient had the first shot of Pfizer COVID vaccine on 12Mar2021 and supposed to have the second dose on 06Apr2021, Tuesday. The patient received the first dose from 02:30 to 03:00 PM on 12Mar2021, and the night at 07:00 PM, had developed itchiness from head to toes. The patient took loratadine (CLARITIN) that night, and the next morning on 13Mar2021, the itchiness resolved. The patient also experienced stomach cramping which eased with a bowel movement. Stated that she had 8 bowel movements that day. The patient was wondering whether she should receive the second dose. The patient would like to know if she should take loratadine (CLARITIN) before her second shot if she decided to get the second shot. The outcome of event itchiness from head to toes was recovered on 13Mar2021; the event stomach cramping was recovering; the event had 8 bowel movements was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Itching; This is a spontaneous report from a contactable consumer (patient). A 44-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, Lot number was not reported), via an unspecified route of administration, administered in left arm on 31Mar2021 at 14:00 (age at vaccination was 44-year-old) as dose 1, single for COVID-19 immunization. The patient's medical history included allergy to nuts. The patient's concomitant medications included a cholesterol medicine (as reported) from Feb2021. On 31Mar2021 (reported as at night), the patient experienced itching. It was reported that the patient took diphenhydramine (BENADRYL, 25 mg), so she was better and was not itching anymore. She also state that she took ibuprofen 800 mg and was not experiencing anything anymore. The patient said that she saw itching was listed as a possible side effect and would like to know if she was good with taking the second shot. The outcome of the event was recovered on an unspecified date of 2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Lip swelling, Swelling face
Clinical narrative: facial swelling/cheek swelling; lip swelling; This is a spontaneous report from a contactable other hcp . A 64-years-old male patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 1, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. Two days after the first dose of the Pfizer covid-19 vaccine, the patient experienced facial, lip swelling and cheek swelling. There was not anything serious like tongue and throat swelling. The patient's reaction was not serious and resolved after treatment with Benadryl. The patient was asking if patient get the second dose of the Pfizer covid-19 vaccine. Therapeutic measures were taken as a result of events with Benadryl. The outcome of events were recovered on an unspecified date.  No follow-up attempts are needed. Information about lot/batch number cannot be requested. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Choking sensation, Dysstasia, Gait inability, Jaw disorder
Clinical narrative: choking sensation in neck; jaw felt like it was getting huge; couldn't stand; couldn't walk; This is a spontaneous report from a contactable consumer (patient) received via the Medical Information Team. An 86-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), via an unspecified route of administration, on 18Mar2021 (Batch/Lot number was not reported) as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date in Mar2021, the patient experienced choking sensation in neck. It was really bad, her daughter gave her many glasses of water and that seemed to help. Her jaw felt like it was getting huge and she couldn't stand or walk for a few days. Her doctor told her to take paracetamol (TYLENOL) and diphenhydramine (BENADRYL) before and after she gets the vaccine. The patient asked if she should get the second vaccine. It was scheduled on 08Apr2021. The outcome of events choking sensation in neck, jaw felt like it was getting huge, couldn't stand, and couldn't walk was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pain, Pain in extremity, Pyrexia
Clinical narrative: sore arm; low grade fever; chills; body aches; This is a spontaneous report from a contactable consumer (patient).  A 39-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number and expiration date: not reported), via an unspecified route of administration, on an unspecified date, as DOSE 2, SINGLE for covid-19 immunization. The patient's medical history and concomitant medications were not reported.  Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), as DOSE 1, SINGLE for covid-19 immunization. The patient experienced sore arm, low grade fever, chills and body aches on an unspecified date. The outcome of the events was unknown at time of report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Lethargy, Pyrexia, Vaccination site discomfort
Clinical narrative: Right arm injection site discomfort; Low grade fever; Lethargy; This is a spontaneous report from a contactable consumer via a Pfizer sales representative. A 50-year-old female patient received bnt162b2 (BNT162B2), via an unspecified route of administration, administered in arm right at the age 50 years old on 30Mar2021 (Batch/Lot number was not reported) as dose number unknown, single for covid-19 immunisation. Medical history and concomitant medications were not reported. On an unspecified date, the patient experienced right arm injection site discomfort, low grade fever and lethargy the next day. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Back pain, Fatigue, Myalgia
Clinical narrative: weakness; myalgia; fatigue; joint/lower back pain; joint/lower back pain; This is a spontaneous report from a non-contactable consumer (patient) received via a sales representative. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported), via an unspecified route of administration on 31Mar2021 as dose 2, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced weakness, myalgia, fatigue and joint/lower back pain on 31Mar2021. Outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pyrexia
Clinical narrative: chills; fever; fatigue; This is a spontaneous report from a contactable consumer (patient).   A patient of unspecified age and gender received bnt162b2 (BNT162B2), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunisation.  The patient's medical history and concomitant medications were not reported.  The patient experienced chills, fever, and fatigue.  The outcome of the events was recovered after 24hours.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Exposure to SARS-CoV-2, Headache, Hypersensitivity, Lacrimation increased, Nasal congestion
Clinical narrative: at his workplace, one of the technicians tested positive; my allergies seem to be in my head; headache; My arm was a little sore too.; my eyes very red; eye watering and nasal congestion; eye watering and nasal congestion; This is a spontaneous report from a contactable consumer (patient). A 49-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, Lot Number: not reported), via an unspecified route of administration on an unspecified date (at the age of 49 years) as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient reported, after 4 days of first dose he had eyes watering and nasal congestion on 01Apr2021. It was like he was having allergies. At his workplace, one of the technicians tested positive, he felt like allergies seem to be in his head and between his eyes and he had a headache. His arm was a little sore too. He was feeling tiredness (not clear, hence not captured as event) his eyes very red, like allergy symptoms like that. The clinical outcome of the events lacrimation increased and nasal congestion was not recovered; unknown for the rest of the events.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Ocular hyperaemia, Pain in extremity
Clinical narrative: at his workplace, one of the technicians tested positive; my allergies seem to be in my head; headache; My arm was a little sore too.; my eyes very red; eye watering and nasal congestion; eye watering and nasal congestion; This is a spontaneous report from a contactable consumer (patient). A 49-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, Lot Number: not reported), via an unspecified route of administration on an unspecified date (at the age of 49 years) as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient reported, after 4 days of first dose he had eyes watering and nasal congestion on 01Apr2021. It was like he was having allergies. At his workplace, one of the technicians tested positive, he felt like allergies seem to be in his head and between his eyes and he had a headache. His arm was a little sore too. He was feeling tiredness (not clear, hence not captured as event) his eyes very red, like allergy symptoms like that. The clinical outcome of the events lacrimation increased and nasal congestion was not recovered; unknown for the rest of the events.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Pain, Pain in extremity, Urticaria
Clinical narrative: Shooting pain from shoulder to fingers on both arms/Shooting pain from shoulder to fingers on both arms; Extreme pain 12/10.; Arms got hotter than rest of body; Hives; This is a spontaneous report from a contactable other health professional(patient). A 32-year-old non-pregnant female patient received first dose of BNT162B2(PFIZER BIONTECH COVID19 vaccine, Solution for injection, Batch/Lot Number: ER8732) via an unspecified route of administration, administered in Arm Left on 24Mar2021 10:00 (At the age of 32-year-old) as single dose for COVID-19 immunisation. Medical history included food allergy, hypersensitivity to drywall, mok orange, allergy to arthropod bite, iodine allergy,allergy to animal, allergy to arthropod sting, seasonal allergy from an unknown date. Concomitant medications included clarithromycin (MACROBID) taken for an unspecified indication, start and stop date were not reported.The patient didn ot received any other vaccines within 4 weeks prior to the COVID vaccine.Prior to vaccination patient was not diagnosed with COVID-19 and Since the vaccination, the patient had not been tested for COVID-19. On 03Apr2021 03:00 the patient experienced shooting pain from shoulder to fingers on both arms/shooting pain from shoulder to fingers on both arms, extreme pain 12/10, arms got hotter than rest of body and hives on 29Mar2021 20:00. The outcome of the events was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Eye swelling, Lip swelling, Urticaria
Clinical narrative: hives all over the body; lip swelled up as well as the right eye; lip swelled up as well as the right eye; This is a spontaneous report from a contactable healthcare professional (patient) received via agency. A 20-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), via an unspecified route of administration, administered in right arm, on 14Jan2021 at 11:30 AM (Batch/Lot Number: EK5730) (at the age of 20 years old) as dose 2, single for COVID-19 immunisation in a workplace clinic. The patient has no relevant medical history. The patient was not diagnosed with COVID-19 prior to vaccination and has not been tested for COVID-19 since the vaccination. The patient has no known drug allergies. The patient was not pregnant at the time of vaccination. Concomitant medication included ibuprofen 600mg tablet, taken as needed for unspecified indication. The patient was previously administered the first dose of BNT162B2, via an unspecified route of administration, administered in right arm, on 23Dec2020 at 11:45 AM (Batch/Lot Number was not reported) (at the age of 20 years old) as dose 1, single for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 14Jan2021 at 19:30, 8 hours after the second dose of vaccination, the patient experienced hives all over the body and lip swelled up as well as the right eye. This has been happening since the second vaccine on 14Jan2021 until today, 03Apr2021. These episodes of hives and swelling happened at least 3 times a week. The healthcare professional reported the events as non-serious. The patient received no treatment for the events. The outcome of all events was recovering.  No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Muscle spasms, Pyrexia
Clinical narrative: back spasms; FEVER 102 for several hours; This is a spontaneous report from a contactable consumer.   A non-pregnant adult female patient of unknown age received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration on an unknown date in Feb2021 as a single dose for COVID-19 immunisation. It was unknown if patient had any medical history. It was unknown if patient had allergies to food, medications, or other products. The patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation and experienced back spasms. It was unknown if prior to vaccination the patient was diagnosed with COVID-19. It was unknown if since the vaccination the patient had been tested for COVID-19. It was unknown whether the patient received any other vaccines within four weeks prior to the vaccination. It was unknown whether the patient received other medications within 2 weeks of vaccination. On an unknown date in Feb2021, the patient experienced back spasms and fever of 102 for several hours with the second shot. On an unknown date, the patient underwent tests which include body temperature and the result was 102 (units unspecified). It was unknown whether the patient received treatment for the events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event fever 102 and back spasms was recovered on an unknown date in 2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Increased upper airway secretion, Rash
Clinical narrative: rash on arm; mucous in her throat; Teeth chattering; This is a spontaneous report from a non-contactable consumer (parent). A 16-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection, lot number, expiration date was not reported) via an unspecified route of administration, on Mar2021 (at the age of 16-year-old), at dose 1, single for covid-19 immunization. Medical history included allergies to tree nuts; had anaphylactic reactions to tree nuts. The patient's concomitant medications were not reported. The patient experienced rash on arm, mucous in her throat, and teeth chattering on Mar2021. Therapeutic measures were taken included Benadryl and she was fine. The outcome of the event was recovered on Mar2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Pain in extremity, SARS-CoV-2 test
Clinical narrative: Sore arm; Shoulder pain a little bit; This is a spontaneous report from a contactable consumer (patient). A 72-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EN6200), via an unspecified route of administration, in left arm on 18Feb2021 (at the age of 72-years-old) as dose 2, single for COVID-19 immunization. The patient's medical history was not reported. There were no concomitant medications. Historical vaccine included flu shots, shingles vaccine, pneumonia vaccine and BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EL9262), via an unspecified route of administration, in left arm on 28Jan2021 as dose 1, single for COVID-19 immunization after which the patient experienced painful arm, shoulder pain, vaccination site pain and incorrect product administration duration. The patient experienced sore arm on 18Feb2021 and shoulder pain a little bit in Feb2021. The patient underwent lab tests and procedures which included sars-cov-2 test: negative. The outcome of event sore arm was 18Feb2021 and event shoulder pain a little bit was recovered in Feb2021.   No follow-up attempts needed. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Hyperhidrosis, Malaise, Pyrexia
Clinical narrative: malaise; fever; sweats; This is a spontaneous report from a contactable pharmacist (patient). A patient of unspecified age and gender received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history was not reported. The first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) was administered on 10Mar2021 for covid-19 immunisation and experienced soreness in arm. The patient's concomitant medications were not reported. After second dose of Covid vaccine, patient developed malaise, fever, and sweats on an unspecified date. Outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Oedema, Peripheral swelling, Swelling
Clinical narrative: Swelling of the feet and lower legs; 4lbs water weight gain overnight; intermittent swelling; This is a spontaneous report from a non-contactable physician (patient) via sales representative. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on 14Feb2021 (Batch/Lot number was not reported) as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced swelling of the feet and lower legs, 4lbs water weight gain overnight, and intermittent swelling. Events were treated with aspirin. The outcome of the events was recovered on an unspecified date.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain, Pyrexia, Vaccination site pain
Clinical narrative: Fairly sore arm near injection site; Slight fever; Tired; Achy; This is a spontaneous report from a contactable consumer (patient). A 44-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number: EP6955, Expiration date: Not reported), via an unspecified route of administration in right arm on 30Mar2021 at 14:45 (at the age of 44-years-old) as dose 2, single for COVID-19 immunization in a workplace clinic. There were no patient's relevant medical history reported. No known allergies to medications, food, or other products. Concomitant medications/other medications received within 2 weeks of vaccination included fexofenadine hydrochloride (ALLEGRA); cyanocobalamin (VITAMIN B12); esomeprazole sodium (NEXIUM); probiotics and glucosamine. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number: EL3247, Expiration date: Not reported), via an unspecified route of administration in right arm on 09Mar2021 at 14:30 (at the age of 44-years-old) as dose 1, single for COVID-19 immunization and experienced right arm soreness near the injection site. The patient was not pregnant at the time of vaccination and didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. The patient experienced fairly sore arm near injection site, slight fever, tired and achy on 31Mar2021 at 09:00. No treatment was received by the patient for these adverse events. These events were considered as non-serious and the outcome of these events was reported as recovering at the time of report.   No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Hypersensitivity, Nasal pruritus, Pain in extremity, Pruritus
Clinical narrative: Itchy nostrils; Left arm hurt a little; Left arm was a little itchy; It is also pink; Allergy related; This is a spontaneous report from a contactable consumer (patient). A non-pregnant 80-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number was not reported), via an unspecified route of administration in left arm, on 25Mar2021 at 02:00 PM (14:00), as dose 2, single, for COVID-19 immunization. The patient's medical history included mild emphysema, eye (map dot fingerprint dystrophy; cornea not smooth), irritable bowel syndrome (sometimes), eye pressure, allergies to many foods (chocolate, nuts, tomatoes, etc.), stomach, and allergy. The patient's concomitant medications included loratadine (CLARITIN) for allergy and aluminium magnesium silicate (GELUSIL) for stomach. The patient previously received the first dose of BNT162B2 (Lot Number: EM9810) on 04Mar2021 at 03:00 PM for COVID-19 immunization and experienced tongue burns (tongue started to bother her and is still bothering her); and cyanocobalamin (B-12) and gold and experienced allergies to both. The most recent vaccine was administered in a hospital facility. In Mar2021 at 02:30 PM (also reported as on 04Mar2021 and on the seventh day after the second vaccine was administered; clarified as after the second vaccine), the patient had itchy nostrils almost immediately and her left arm hurt a little and was a little itchy. The patient looked at it and it is also pink. This was possible right after the shot, but this is a week (as reported). The doctors say it's nothing but to the patient it's been going on for quite a while. The patient thinks that most of this is allergy related (Mar2021). The adverse events resulted in doctor or other healthcare professional office or clinic visit. No treatment was administered for the adverse events. The patient underwent COVID-19 nasal swab test (rapid) on 29Mar2021 that was negative. The patient had not recovered from the events.  No follow-up attempts are possible; information about lot or batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: Itchy nostrils; Left arm hurt a little; Left arm was a little itchy; It is also pink; Allergy related; This is a spontaneous report from a contactable consumer (patient). A non-pregnant 80-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number was not reported), via an unspecified route of administration in left arm, on 25Mar2021 at 02:00 PM (14:00), as dose 2, single, for COVID-19 immunization. The patient's medical history included mild emphysema, eye (map dot fingerprint dystrophy; cornea not smooth), irritable bowel syndrome (sometimes), eye pressure, allergies to many foods (chocolate, nuts, tomatoes, etc.), stomach, and allergy. The patient's concomitant medications included loratadine (CLARITIN) for allergy and aluminium magnesium silicate (GELUSIL) for stomach. The patient previously received the first dose of BNT162B2 (Lot Number: EM9810) on 04Mar2021 at 03:00 PM for COVID-19 immunization and experienced tongue burns (tongue started to bother her and is still bothering her); and cyanocobalamin (B-12) and gold and experienced allergies to both. The most recent vaccine was administered in a hospital facility. In Mar2021 at 02:30 PM (also reported as on 04Mar2021 and on the seventh day after the second vaccine was administered; clarified as after the second vaccine), the patient had itchy nostrils almost immediately and her left arm hurt a little and was a little itchy. The patient looked at it and it is also pink. This was possible right after the shot, but this is a week (as reported). The doctors say it's nothing but to the patient it's been going on for quite a while. The patient thinks that most of this is allergy related (Mar2021). The adverse events resulted in doctor or other healthcare professional office or clinic visit. No treatment was administered for the adverse events. The patient underwent COVID-19 nasal swab test (rapid) on 29Mar2021 that was negative. The patient had not recovered from the events.  No follow-up attempts are possible; information about lot or batch number cannot be obtained. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Inflammation, Lymphadenopathy
Clinical narrative: swollen, red lymph node; 2 months after 2nd vaccine swollen, red lymph node came back in same armpit has been inflamed one week to date; swollen, red lymph node; This is a spontaneous report from a contactable consumer (Patient). A 52-year-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number was not reported), via an unspecified route of administration, administered in Arm Left on 05Feb2021 as dose 2, single for covid-19 immunisation from hospital. Medical history high blood pressure, hypothyroidism, depression, allergies to several antibiotics. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and Patient received prescription medications within 2 weeks of vaccination. The patient was not diagnosed with covid prior to vaccination and patient was not tested for COVID-19 post vaccination. The patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number was not reported), via an unspecified route of administration, administered in Arm Left on 15Jan2021 as dose 1, single for covid-19 immunisation and had Large swollen lymph node in armpit of shot went away after 2 weeks. In 2 months after 2nd vaccine patient experienced swollen, red lymph node came back in same armpit has been inflamed one week to date. The patient did not receive any treatment in response to the events. The outcome of the events was not recovered.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: itching; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced itching on an unspecified date. Outcome of event was resolved on an unspecified date.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021366674 Same reporter/drug/event for different patients.